^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    BIOMARKER:

    PD-L1 underexpression + EGFR mutation

    i
    Other names: EGFR, ERBB, ERBB1, Epidermal growth factor receptor, PD-L1, CD274, HPD-L1, PD-L1, B7H1, PDL1, Programmed death ligand 1, B7-H1, B7-H, PDCD1L1, PDCD1LG1, PDCD1 Ligand 1, B7 homolog 1, CD274 Antigen, Programmed cell death 1 ligand 1, CD274 molecule
    Entrez ID:
    1956; 29126
    Related biomarkers:
    Expression
    Mutation
    CNA
    Fusion
    Others
    over3years
    Hypoxia-related lncRNAs to build prognostic classifier and reveal the immune characteristics of EGFR wild type and low expression of PD-L1 squamous and adenocarcinoma NSCLC. (PubMed, Cancer Med)
    It is noteworthy that hypolncRNAs are associated with the survival of double-negative LUAD and LUSC patients, for which the possible mechanism is inhibiting the antitumor immune process.
    Journal • PD(L)-1 Biomarker • IO biomarker
    |
    EGFR (Epidermal growth factor receptor) • PD-L1 (Programmed death ligand 1)
    |
    PD-L1 expression • EGFR mutation • EGFR expression • PD-L1 underexpression • PD-L1 underexpression + EGFR mutation